ISAF Hybrid 2023
BackWithdrawal of inhaled corticosteroids in severe T2-low obesity-related asthma: results from an open-label randomized crossover trial
Friday 06 Oct, 10:06 AM -
10:17 AM Europe/Rome
Sala Germania
Oral Presentations